Facing COVID-19 in the ICU: vascular dysfunction, thrombosis, and dysregulated inflammation
- PMID: 32347323
- PMCID: PMC7186535
- DOI: 10.1007/s00134-020-06059-6
Facing COVID-19 in the ICU: vascular dysfunction, thrombosis, and dysregulated inflammation
Conflict of interest statement
ML received research funds from the french ministry of health, research support from Shingotec, lecture fees from Baxter and Fresenius and consulting fees from Novartis. The other authors have no conflict of interest.
Figures
Comment in
-
Don't lose sight of maintenance fluids' main role: to provide free water!Intensive Care Med. 2020 May;46(5):1074-1076. doi: 10.1007/s00134-020-05989-5. Epub 2020 Mar 11. Intensive Care Med. 2020. PMID: 32162031 No abstract available.
Comment on
-
COVID-19 Does Not Lead to a "Typical" Acute Respiratory Distress Syndrome.Am J Respir Crit Care Med. 2020 May 15;201(10):1299-1300. doi: 10.1164/rccm.202003-0817LE. Am J Respir Crit Care Med. 2020. PMID: 32228035 Free PMC article. No abstract available.
-
COVID-19 pneumonia: different respiratory treatments for different phenotypes?Intensive Care Med. 2020 Jun;46(6):1099-1102. doi: 10.1007/s00134-020-06033-2. Epub 2020 Apr 14. Intensive Care Med. 2020. PMID: 32291463 Free PMC article. No abstract available.
References
-
- Sinha P, Delucchi KL, McAuley DF, O’Kane CM, Matthay MA, Calfee CS. Development and validation of parsimonious algorithms to classify acute respiratory distress syndrome phenotypes: a secondary analysis of randomised controlled trials. Lancet Respir Med. 2020;8(3):247–257. doi: 10.1016/S2213-2600(19)30369-8. - DOI - PMC - PubMed
